De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
Text message-based health surveys distributed to 6,694 Liberians during an Ebola outbreak were generally on par with baseline demographic data collected in a prior household survey, according to a study recently published in Nature Digital Medicine. Further, the text surveys suggested that women sought fewer hospital-based deliveries during the outbreak, a trend consistent with other...
Sotera Wireless's ViSi Mobile monitor.
The Scripps Translational Science Institute (STSI) has received a grant from the US Agency for International Development (USAID) to create a program that will use health sensors to improve the health outcomes of Ebola patients. The program is called STAMP2, short for Sensor Technology and Analytics to Monitor, Predict and Protect Ebola Patients.
STSI...
While a tiny percentage of Ebola cases are popping up in the United States and Europe, the epicenter of the disease is and remains in West Africa, an area where mobile health initiatives are often deployed, especially those that take advantage of text messaging and other short message services. Texting is a good way to educate a large swath of the population so they can identify symptoms of the...
Although relatively few cases have been reported outside West Africa, Ebola is both a top headline and a public health concern in the Western world, with eight confirmed cases in the United States. Even in the UK, Ebola was a topic of discussion at a recent TechCrunch Disrupt Conference panel on digital health.
"I think the question is no longer if, but it's when," Dominic King, a surgeon at...
